Allogeneic Transplantation Model
Allogeneic Transplantation Model - Related Videos
06:48
Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice
0 Views •
Cited by 10 •
2014
Tail-skin transplantation is a powerful model for studying T cell-dependent rejection and tolerance induction during allogeneic immune responses in mice. The advantages of this protocol are minor invasive surgery, and ease of monitoring with no need to sacrifice the recipient mouse.
05:54
Induction of Graft Versus Host Disease in Mouse Models via Allogeneic Bone Marrow and Splenic Cell Transplantation
0 Views •
2025
This video demonstrates the induction of intestinal graft-versus-host disease, GvHD, in a lethally-irradiated recipient mouse using allogeneic hematopoietic stem cells and GvHD-inducing splenic alloreactive T lymphocytes. This protocol helps establish a severe acute intestinal GvHD model to understand the mechanism of the disease and develop innovative therapeutic options.
08:15
Cervical Heterotopic Mouse Heart Transplantation using End-to-side Anastomosis Technique to Study Transplant Immunology
0 Views •
Cited by 1 •
2026
This protocol presents a simplified, end-to-side suture anastomosis technique for murine cervical heart transplantation, providing a robust and reproducible model for studying transplant immunology.
09:01
A Quantitative Assessment of the Phagocytosis of Allogeneic and Xenogeneic Erythrocytes by Rat Macrophages In Vitro
0 Views •
2025
This work describes a standardized in vitro protocol to quantify and compare the phagocytosis rates of xenogeneic (human) and allogeneic (rat) red blood cells by isolated rat macrophages.
09:11
A Mouse Model of in Utero Transplantation
0 Views •
Cited by 26 •
2011
The mouse model of in utero transplantation is a versatile tool that can be used to study the potential clinical applications of stem cell transplantation and gene therapy in the fetus. In this protocol, we present a general approach to performing this...
FAQs
The response begins when recipient immune cells recognize donor antigens as foreign. This recognition can activate both cellular and antibody-mediated pathways, creating biological pressure that affects whether the graft is accepted, rejected, or brought toward tolerance. Comparing these outcomes helps researchers examine how immune recognition and regulation shape compatibility between transplanted material and its recipient.
Genetic differences between donor and recipient influence how the recipient immune system perceives transplanted cells, tissues, or organs. These differences provide a basis for studying histocompatibility, meaning the biological compatibility relevant to transplantation. By relating genetic variation to acceptance or rejection, the model helps clarify why transplantation outcomes differ among donor-recipient combinations.
Cellular and antibody-mediated pathways represent two immune mechanisms that can influence a graft after transplantation. Their activation may contribute to rejection, while immune regulation may support acceptance or tolerance. Examining these pathways separately and together allows investigators to evaluate which aspects of the recipient response are associated with unfavorable outcomes or improved graft persistence.
A typical study transfers donor cells, tissue, or an organ to a genetically different recipient of the same species, then examines the recipient response and resulting graft status. Researchers can assess immune recognition, compatibility, and whether the outcome reflects acceptance, rejection, or tolerance. The design may also support evaluation of an immunosuppressive strategy.
Researchers use the model when they need to examine how genetic differences and immune regulation affect transplanted material. Its applications include investigating tissue repair, histocompatibility, graft acceptance or rejection, and overall transplantation outcomes. Because the system connects immune responses with transplanted cells, tissues, or organs, it provides a biological framework for comparing these processes.
The model provides a controlled setting for observing whether an immunosuppressive strategy changes the recipient response to donor material. Researchers can compare outcomes such as graft acceptance, rejection, or tolerance while considering cellular and antibody-mediated immune pathways. This makes the system useful for connecting a strategy with measurable changes in compatibility and transplantation outcome.